{"id":"W2503609914","doi":"10.1093/ecco-jcc/jjw137","title":"Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease","year":2016,"lang":"en","type":"review","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Takeda Oncology; Tillotts Pharma; Bristol-Myers Squibb","keywords":"Drug development; Crohn's disease; Drug; Disease; Intensive care medicine; Pharmacokinetics; Pharmacodynamics; Dosing; Medicine; Risk analysis (engineering); Computer science; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004229697,0.0009970997,0.00168429,0.002725583,0.0004872874,0.002726852,0.001612621,0.002786621,0.002632853],"category_scores_gemma":[0.002928862,0.000509956,0.0008621677,0.002428161,0.002191392,0.004084466,0.001475791,0.00522883,0.001912088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001821121,"about_ca_system_score_gemma":0.002647256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009822915,"about_ca_topic_score_gemma":0.001663527,"domain_scores_codex":[0.9987373,0.0003555404,0.0002061743,0.0001888301,0.0004174211,0.00009474411],"domain_scores_gemma":[0.9980062,0.001188654,0.0002631653,0.00007442682,0.0003306728,0.0001369692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008886469,0.00009311022,0.0001923828,0.01474133,0.00005742862,0.0002738515,0.0001436024,0.0006315212,0.001402011,0.02133545,0.01414626,0.9468941],"study_design_scores_gemma":[0.00003187291,0.0002122316,0.0005557513,0.005102218,0.00006558427,0.001804592,0.0001336009,0.0001801837,0.0007208735,0.01092179,0.9802375,0.00003381251],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001105098,0.996983,0.0006220058,0.0009628744,0.0002731153,0.00001031264,0.000008643678,0.000009931068,0.001019565],"genre_scores_gemma":[0.001242809,0.9958579,0.001241916,0.000764125,0.0003186793,0.00002075028,0.0000165481,0.000004337061,0.0005328836],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004229697,"threshold_uncertainty_score":0.02236903,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01522170544122095,"score_gpt":0.3079002505947149,"score_spread":0.292678545153494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}